These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22378679)

  • 1. New peptide deformylase inhibitors and cooperative interaction: a combination to improve antibacterial activity.
    Goemaere E; Melet A; Larue V; Lieutaud A; Alves de Sousa R; Chevalier J; Yimga-Djapa L; Giglione C; Huguet F; Alimi M; Meinnel T; Dardel F; Artaud I; Pagès JM
    J Antimicrob Chemother; 2012 Jun; 67(6):1392-400. PubMed ID: 22378679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide deformylase as an antibacterial target: a critical assessment.
    Leeds JA; Dean CR
    Curr Opin Pharmacol; 2006 Oct; 6(5):445-52. PubMed ID: 16904375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship analysis and therapeutic potential of peptide deformylase inhibitors.
    Boularot A; Giglione C; Artaud I; Meinnel T
    Curr Opin Investig Drugs; 2004 Aug; 5(8):809-22. PubMed ID: 15600237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of peptide deformylase as a target: contribution of biochemistry, genetics and genomics.
    Yuan Z; White RJ
    Biochem Pharmacol; 2006 Mar; 71(7):1042-7. PubMed ID: 16289392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antibiotic molecules: bypassing the membrane barrier of gram negative bacteria increases the activity of peptide deformylase inhibitors.
    Mamelli L; Petit S; Chevalier J; Giglione C; Lieutaud A; Meinnel T; Artaud I; Pagès JM
    PLoS One; 2009 Jul; 4(7):e6443. PubMed ID: 19649280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
    Yang S; Shi W; Xing D; Zhao Z; Lv F; Yang L; Yang Y; Hu W
    Eur J Med Chem; 2014 Oct; 86():133-52. PubMed ID: 25151577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates.
    Jones RN; Moet GJ; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2004 May; 53(5):804-7. PubMed ID: 15056649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.
    Hu X; Nguyen KT; Jiang VC; Lofland D; Moser HE; Pei D
    J Med Chem; 2004 Sep; 47(20):4941-9. PubMed ID: 15369398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches to antimicrobial therapy: peptide deformylase.
    Waller AS; Clements JM
    Curr Opin Drug Discov Devel; 2002 Sep; 5(5):785-92. PubMed ID: 12630299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
    Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship analysis of the peptide deformylase inhibitor 5-bromo-1H-indole-3-acetohydroxamic acid.
    Petit S; Duroc Y; Larue V; Giglione C; Léon C; Soulama C; Denis A; Dardel F; Meinnel T; Artaud I
    ChemMedChem; 2009 Feb; 4(2):261-75. PubMed ID: 19053131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide deformylase as an antibacterial drug target: assays for detection of its inhibition in Escherichia coli cell homogenates and intact cells.
    Apfel CM; Evers S; Hubschwerlen C; Pirson W; Page MG; Keck W
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1053-7. PubMed ID: 11257015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.
    Jain R; Chen D; White RJ; Patel DV; Yuan Z
    Curr Med Chem; 2005; 12(14):1607-21. PubMed ID: 16022661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide deformylase inhibitors with non-peptide scaffold: synthesis and structure-activity relationships.
    Lee SK; Choi KH; Lee SJ; Lee JS; Park JY; Kim BM; Lee BJ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):133-6. PubMed ID: 21146987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.
    Clements JM; Beckett RP; Brown A; Catlin G; Lobell M; Palan S; Thomas W; Whittaker M; Wood S; Salama S; Baker PJ; Rodgers HF; Barynin V; Rice DW; Hunter MG
    Antimicrob Agents Chemother; 2001 Feb; 45(2):563-70. PubMed ID: 11158755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical study of Escherichia coli peptide deformylase inhibition by several drugs.
    Chikhi A; Bensegueni A; Boulahrouf A; Bencharif M
    In Silico Biol; 2006; 6(5):459-66. PubMed ID: 17274774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peptide-deformylase inhibitors, a new class of antibiotics].
    Dubreuil L
    Presse Med; 2002 Nov; 31(38):1810-2. PubMed ID: 12497724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.
    Chen DZ; Patel DV; Hackbarth CJ; Wang W; Dreyer G; Young DC; Margolis PS; Wu C; Ni ZJ; Trias J; White RJ; Yuan Z
    Biochemistry; 2000 Feb; 39(6):1256-62. PubMed ID: 10684604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
    Sharma A; Khuller GK; Sharma S
    Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial agents: patent highlights July to December 2002.
    Phillips OA
    Curr Opin Investig Drugs; 2003 Feb; 4(2):117-27. PubMed ID: 12669371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.